Head and Neck Non-Keratinizing Squamous Cell Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Head and Neck Non-Keratinizing Squamous Cell Carcinoma

subtype

Identifier: CI-CAN-00005458
Entity page: /cancer/head-and-neck-non-keratinizing-squamous-cell-carcinoma ↗
Edges: 44

Neighbours: 20 drugs10 trials
Drawn: 30 of 30 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Head and Neck Non-Keratinizing Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived20 of 20show fewer
→ investigated in trials for	Bevacizumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Head and Neck Non-Keratinizing Squamous Cell Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for

Head and Neck Non-Keratinizing Squamous Cell Carcinoma studied in …STUDIED_INderived10 of 24show all (up to 200)
→ studied in	NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04458909Phase 3 · terminated Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Non-Keratinizing Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ALIAS · 24 trials mapped (2 active)	—	—	Sinonasal Non-Keratinizing Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00274937Phase 3 · completed Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00896181Phase 2 · completed Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02794077Phase 2 · completed Cyclophosphamide for Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 24 trials mapped (2 active)	—	—	Nasopharyngeal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02339558Phase 2 · completed Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer · condition mapped ALIAS · 24 trials mapped (2 active)	—	—	Nasopharyngeal Non-Keratinizing Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains